14th Biosimilars Global Congress 2019 Europe
25 Nov,2019 - 26 Nov,2019
A Little Teaser
Biosimilars market in Europe, having reached the most advance stage in the process globally is still continuously gathering strength. In the recent year alone, 19 biosimilar therapeutic medicines had been granted marketing authorization, which brings over 40 EC-approved biosimilar products in the current market. Europe is bound to have another remarkable year of biosimilar approvals and launches in this coming year with EMA’s pipeline of biosimilar candidate reviews rapidly increasing.
The 14th Biosimilars Global Congress will cover a diverse range of topics that address the Strategies, Innovations and Collaborations for Sustainable Biosimilars. This will also offer and provide a unique platform for knowledge sharing and convergence from Pharmaceuticals, Biotechnology, Regulatory and many more.